🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The Women's Ischemia Study Evaluation (WISE), a cohort study of over 1000 w...
Status
Recruiting
Location
Cedars-Sinai Women's Heart Center
Start Date
2015-10
Trial ID
NCT02582021
The study is prospective, open, randomized, crossover in steady state and t...
Status
Completed
Location
GSK Investigational Site
Start Date
2009-09-09
Trial ID
NCT01316926
Treatments Being Tested
The purpose of this study is to assess how well laroprovstat and ezetimibe ...
Status
Active Not Recruiting
Location
Research Site
Start Date
2026-06-10
Trial ID
NCT07622433
The aim of the TRICIDIA2 study is to compare two modalities of administrati...
Status
Unknown
Location
CHU
Start Date
2012-01
Trial ID
NCT01889914
Treatments Being Tested
The main goal is to reveal differences in global gene expression in two dif...
Status
Active Not Recruiting
Location
AdventHealth Translational Research Institute
Start Date
2020-01-31
Trial ID
NCT04034706
This is a single site blinded RCT of 920 pregnant women with singleton gest...
Status
Completed
Location
UPMC- Magee Womens Hospital
Start Date
2015-08-11
Trial ID
NCT02309138
Muscle atrophy may occur in individuals with spinal cord injury (SCI) as a ...
Status
Completed
Location
Multiple Locations
Start Date
2014-09-21
Trial ID
NCT03859960
Treatments Being Tested
The goal of this study is to analyze in treatment-naïve HIV patients the an...
Status
Completed
Location
Hospital Universitario Virgen de Las Nieves
Start Date
2020-10-27
Trial ID
NCT06177574
Treatments Being Tested
The continual glucose is going to increase time-in-range compared to the st...
Status
Completed
Location
OHSU
Start Date
2021-02-11
Trial ID
NCT04605497
Treatments Being Tested
In order to assess the potential impact of steady state BI 425809 on CYP3A ...
Status
Completed
Location
Humanpharmakologisches Zentrum Biberach
Start Date
2022-03-18
Trial ID
NCT05258110
Treatments Being Tested